Overview

LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Advanced HCC represents a high unmet medical need with a poor prognosis and few therapeutic options. Patients who present with HCC beyond the currently accepted Milan criteria are not eligible to be listed for liver transplantation. The proposed study offers local regional therapy to a defined population of patients beyond Milan criteria as an attempt to downstage them to eligibility for liver transplant.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
Biocompatibles UK Ltd
Treatments:
Doxorubicin
Liposomal doxorubicin